First Pill for Postpartum Depression Is Approved by FDA
The pill, to be taken daily for at least two weeks, significantly reduced postpartum depression among new mothers in a...
service testing
FDA Approves GSK’s RSV Vaccine for Older Adults
HealthApproval of respiratory syncytial virus vaccine is a first for people 60 years and older, company says Source link
Moderna, Merck Show Progress Toward Cancer Vaccines
An mRNA shot helped prevent relapse in high-risk melanoma patients. Source link
Moderna Reports RSV Vaccine Cuts Risk of Respiratory Diseases in Older Adults
The company said it would apply in coming months for U.S. regulatory approval. Source link
New Alzheimer’s Drug Leqembi Will Be Out of Reach for Most Patients
HealthMedicare won’t pay for medicine under rule issued to restrict use of earlier drug whose approval generated controversy Source link
Alzheimer’s Drug Slows Disease Progression in Trial
The pharmaceutical companies said their drug lecanemab reduced cognitive and functional decline by 27%, compared with a placebo, over 18...
Sanofi, Glaxo Seek Covid-19 Vaccine Approval in Crowded Market
Sanofi SA and GlaxoSmithKline PLC said they would seek authorization for their Covid-19 vaccine, a sign that pharmaceutical companies still...
FDA Rejects Short Sellers’ Request to Halt Trials of Alzheimer’s Drug
The Food and Drug Administration has denied a petition by short sellers to halt clinical trials of an experimental Alzheimer’s...
Medicare to Pay for Biogen’s New Alzheimer’s Drug in Clinical-Trial Patients
Medicare officials said they would cover Biogen Inc.’s BIIB 2.64% controversial Alzheimer’s disease drug Aduhelm on the condition that patients...
Pfizer to Ask Regulators to Authorize Covid-19 Vaccine Booster
Pfizer Inc. will seek clearance from U.S. regulators in coming weeks to distribute a booster shot of its Covid-19 vaccine...
FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns
The U.S. Food and Drug Administration approved the first new Alzheimer’s drug in decades over the objection of agency statisticians...
CureVac Shares Plunge Premarket on Disappointing Covid-19 Vaccine Trial
Shares in Germany’s CureVac CVAC -3.47% NV fell by almost half in premarket trading, pointing to hefty losses for investors...
Pair of Covid-19 Drugs Performed Well in Studies, Makers Say
A pair of experimental Covid-19 treatments produced positive results in clinical trials, the companies developing the drugs said Monday. Humanigen...
AstraZeneca Releases Covid-19 Vaccine Data Showing 76% Efficacy
AstraZeneca PLC released more pivotal-trial data for its Covid-19 vaccine, saying the shot was 76% effective at preventing Covid-19 with...
U.S. Health Officials Raise Concerns Over AstraZeneca Vaccine Data
U.S. officials said early Tuesday they had been told AstraZeneca PLC may have released outdated information in its disclosure of...
AstraZeneca’s Covid-19 Vaccine Is Safe, 79% Effective in Late-Stage U.S. Trials
AstraZeneca AZN -0.24% PLC’s Covid-19 vaccine was shown to be safe and 79% effective in preventing symptomatic disease in U.S....
Lilly Alzheimer’s Drug Shows Modest Benefit in Clinical Trial
An Eli Lilly LLY 1.40% & Co. experimental drug modestly slowed the cognitive and functional decline of early-stage Alzheimer’s patients...
Drugmakers Look for New Ways to Test Covid-19 Vaccines
As more Covid-19 vaccines become available in the U.S., it is getting tougher to run large clinical trials to test...
Johnson & Johnson Asks U.S. Regulators for Emergency Approval of Its Covid-19 Vaccine
Johnson & Johnson JNJ 0.93% asked U.S. regulators on Thursday to authorize the emergency use of its Covid-19 vaccine, setting...
